Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas November 7, 2026 Neuro-Oncology
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma November 7, 2026 Neuro-Oncology
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery November 7, 2026 Neuro-Oncology
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases November 7, 2026 Neuro-Oncology
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme November 7, 2026 Neuro-Oncology
Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease November 7, 2026 Neuro-Oncology
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma November 7, 2026 Neuro-Oncology
Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma November 7, 2026 Neuro-Oncology
Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme November 7, 2026 Neuro-Oncology
Study of Tissue and Blood Samples From Patients With High-Grade Glioma November 7, 2026 Neuro-Oncology